| Term 
 | Definition 
 
        | disease characterized by: - severe intermittent hemolysis, fever, chills, & sweating that recur every 3rd or 4th day;
 Severe forms:
 - coma, renal failure, diarrhea, pulmonary edema, death may result;
 - relapses may occur months or even years after initial attack;
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | malignant tertian malaria; most lethal form;
 fever recurs every 3rd day;
 no 2ndary tissue forms;
 drug resistant forms are serious problem;
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | benign tertian malaria; most common form;
 fever every 3rd day;
 2ndary tissue forms;
 relapses;
 resistant strains becoming widespread;
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | quartan malaria; fairly rare;
 fever every fourth day;
 no secondary tissue forms;
 |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | infected female anopheles mosquito (definitive host) injects plasmodial sporozites into human (intermediate host) --> sporozites enter hepatic parenchymal cells --> asexual replication to merozites --> invade RBCs --> merozites enlarge & multiply to form schizonts --> RBCs burst, releasing merozoites & metabolites --> fever & chills --> free merozoites infect more RBCs of differentiate into gametocyte (sexual form) --> ingested by another mosquito |  | 
        |  | 
        
        | Term 
 
        | Blood schizonticides - chloroquine, hydroxychloroquine, quinine, quinidine gluconate, mefloquine, pyrimetahamine + proguanil, atovaquone + proquanil, tetracyclines |  | Definition 
 
        | act on erythrocytic forms of parasite; used to suppress symptoms & provide a "clinical cure";
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | act on hepatic stages of parasite; DO NOT suppress symptoms once erythrocytic stages have been established;
 DO knock out 2ndary tissue forms of P. vivax & P. ovale;
 useful in preventing relapses;
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | act on gametocytes; do NOT help individual suffering from malaria but MAY slow spread of dx;
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | erythrocytic forms of parasite have been eradicated & pt is symptom free; |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | all forms of parasite, including any 2ndary tissue forms have been eradicated; |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | prevent initial development of primary hepatic forms of parasite; not practical with most presently available drugs;
 primaquine, pyremethamine, & proguanil seem to have some of this activity
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | commonly used as prophylactic agents; act on erythrocytic forms to suppress symptoms;
 if individual is exposed to P. vivax or P. ovale, these agents do not affect 2ndary tissue forms of parasite & do not prevent relapses;
 |  | 
        |  | 
        
        | Term 
 
        | chloroquine (Aralen), hydroxychloroquine (Plaquenil) |  | Definition 
 
        | blood shizonticides; acts on erythrocytic forms, no effect on 2ndary tissue forms of P. vivax, P. ovale;
 interferes w/ parasite's feeding mechanism;
 suppressive agent - clinical cure for all forms, radical cure for P. falciparum, P. malariae;
 prophylactic uses;
 Orally administered - well absorbed via GI tract;
 Accumulates in skin & retina;
 metabolized by liver - caution in pts w/ liver dx;
 T1/2 = 6-7 days;
 Toxicity (less than quinine):
 - CNS - dizziness, HA, tinnitus;
 - GI upset - take w/ food;
 - retinal & corneal toxicity - monitor visual fcn;
 - immunologic - skin rashes, blood dyscrasias, lupus-like sx - C/I'd in pts w/ psoriasis & porphyria;
 Anti-inflammatory action at HIGH DOSES - used for RA, SLE
 |  | 
        |  | 
        
        | Term 
 
        | quinine, quinidine gluconate |  | Definition 
 
        | Action: - old drug mainly supplanted by chloroquine;
 - acts on erythrocitic forms;
 - gametocytocidal;
 - inteferes w/ plasmodial digestion of Hb;
 - used in tx of chloroquine-resistant P. falciparum;
 PKs: orally effective, T1/2 = 5-16 hrs;
 Actions:
 - analgesia & antipyretic;
 - GI irritaion, N/V;
 - blurred vision & auditory disturbances;
 - depressant effect on heart;
 - birth defects & abortion;
 - skeletal muscle relaxation;
 - "Cinchonism" - syndrome of toxicity - resembles salicylism (HA, nausea, dizziness, blurred vision, tinnitus)
 |  | 
        |  | 
        
        | Term 
 
        | mefloquine (Lariam, Fansimet) |  | Definition 
 
        | effective against chloroquine-resistant strains of P. falciparum; acts on erythrocytic forms of parasites;
 some strains rapidly develop resistance;
 DRUG OF CHOICE for treatment & prophylaxis of chloroquine-resistant P. falciparum;
 Only used orally;
 Less toxic than chloroquine but DOES cause GI upset & depression of myocardium;
 Can cause seizures, aggravates latent psychoses;
 Should NOT be used in pts w/ a history of mental illness or epilepsy;
 CAN be used during pregnancy;
 Use w/ extreme caution in pts w/ cardiovascular disorders, psychiatric problems, or epilepsy
 |  | 
        |  | 
        
        | Term 
 
        | pyrimethamine (Daraprim), proguanil (aka chloroguanid, Paludrine) |  | Definition 
 
        | inhibits parasite's dihydrofolate reductase, main effect on erythrocytic forms; Prophylactic use for chloroquine-resistant strains of P. falciparum;
 Used in combo with sulfonamides (sulfadoxine) for synergistic effect against parasites;
 |  | 
        |  | 
        
        | Term 
 
        | pyrimethamine + sulfadoxine (Fandisar) |  | Definition 
 
        | used for presumptive treatment of malaria (if a person begins to show symptoms, he/she takes drug) |  | 
        |  | 
        
        | Term 
 
        | atovaquone + proquanil (Malarone) |  | Definition 
 
        | new antimalarial drug; one drug is a dihydrofolate reductase inhibitor;
 2nd drug acts by depolarizing parasite's mitochondria & inhibiting electron transport;
 Side Effects - rare (HA, abdominal pain);
 Alternative to mefloquine or doxycycline for prophylaxis against chloroquine-resistant P. falciparum;
 |  | 
        |  | 
        
        | Term 
 
        | tetracyline antibiotics (doxycycline) |  | Definition 
 
        | antimalarial activity & used as alternate or adjunctive drugs for tx & prophylaxis of malaria; |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | tissue schizonticide; active against tissue forms of all species of plasmodia;
 gametocytocidal;
 Will not suppress dx once it has developed;
 Main ADV: kills 2ndary forms of P. vivax & P. ovale;
 NOT used for routine prophylaxis becaues of toxicity;
 GIVEN as follow-up therapy;
 Toxicities:
 - GI upset, HA, dizziness, hemolytic anemia (esp. in pts w/ G6PDH deficiency);
 - teratogenicity;
 |  | 
        |  | 
        
        | Term 
 
        | Acute Uncomplicated Attack |  | Definition 
 
        | chlorquine - clinical cure for most forms; quinidine gluconate, mefloquine (Lariam), pyrimethamine + sulfadoxine (Fansidar), atovaquone + proquanil (Malarone) - used for chloroquine-resistant P. falciparum & other drug resistant forms of P. falciparum;
 doxycycline - adjunct drug;
 |  | 
        |  | 
        
        | Term 
 
        | Prevention of Relapse (radical cure) for P. vivax & P. ovale |  | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | chloroquine - for most non-resistant forms; mefloquine (Lariam) - chloroquine-resistant P. falciparum;
 doxycycline;
 atovaquone + proquanil (Malarone);
 proquanil/chloroguanide (Paludrine);
 pyrimethamine + sulfadoxine (Fansidar) - presumptive therapy;
 primaquine
 |  | 
        |  |